Literature DB >> 8177502

Modulation of immune reactivity by unilateral striatal and mesolimbic dopaminergic lesions.

B Deleplanque1, S Vitiello, M Le Moal, P J Neveu.   

Abstract

Asymmetrical modulation of immune reactivity by central dopaminergic pathways was suggested by previous reports which described an association between alterations of immune response and peculiar patterns of dopamine asymmetries in pathological and physiological situations. In the present experiments, we studied the respective roles of the nigrostriatal and mesolimbic dopaminergic networks in the asymmetrical modulation of immune responses. Lymphocyte proliferation as well as natural killer (NK) cell activity were analysed in mice, 2 weeks after unilateral lesions of dopaminergic projections by in situ injection of 6-hydroxydopamine in the striatum or the nucleus accumbens. After lesions of the striatum, proliferation of splenic lymphocytes was impaired only in the right-lesioned group. Left-lesions appeared to not modify T lymphocyte reactivity. After lesions of the nucleus accumbens, no modification of T lymphocyte mitogenesis was observed but splenic NK cell activity was depressed in left-lesioned mice as compared with controls or right-lesioned animals. Proliferation of B lymphocytes was not affected by striatal or mesolimbic dopaminergic lesions. It was concluded that both striatal and mesolimbic dopaminergic pathways are asymmetrically involved in neuro-immunomodulation. These dopaminergic regions appear to function independently as the effective side as well as the immune parameters that were altered differ according to the structure lesioned.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177502     DOI: 10.1016/0304-3940(94)90489-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Effects of activation and blockade of dopamine D(2) receptors on the immune response in mice with different types of behavior.

Authors:  G V Idova; M A Cheido; E N Zhukova
Journal:  Neurosci Behav Physiol       Date:  2007-09

Review 2.  Neuro-Immune Mechanisms Regulating Social Behavior: Dopamine as Mediator?

Authors:  Ashley M Kopec; Caroline J Smith; Staci D Bilbo
Journal:  Trends Neurosci       Date:  2019-03-16       Impact factor: 13.837

Review 3.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 4.  Close encounters of the monoamine kind: immune cells betray their nervous disposition.

Authors:  Elizabeth J Meredith; Anita Chamba; Michelle J Holder; Nicholas M Barnes; John Gordon
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

5.  Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations.

Authors:  Timothy B Saurer; Stephanie G Ijames; Donald T Lysle
Journal:  J Pharmacol Exp Ther       Date:  2009-03-03       Impact factor: 4.030

Review 6.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.